David S. Moore
Director/Board Member at CORIUM INTERNATIONAL INC
Profile
David S.
Moore is currently a Director at Corium International, Inc. and Tremeau Pharmaceuticals, Inc. He is also a Senior Vice President-US Commercial at Novo Nordisk, Inc. and a Partner at Gurnet Point Capital LLC.
Previously, he was the Chief Executive Officer at Roivant Sciences, Inc. from 2019 to 2020, an Independent Director at Sirona Biochem Corp.
from 2014 to 2017, and the President & Chief Commercial Officer at Cempra, Inc. from 2016 to 2019.
He also held positions as a Director at Alladapt Immunotherapeutics, Inc., and Chief Business Officer at Ocera Therapeutics, Inc. and Tranzyme Pharma, Inc. (Canada).
Mr. Moore received his undergraduate degree from Thomas Jefferson University, his MBA from Lehigh University, and another undergraduate degree from Towson University.
David S. Moore active positions
| Companies | Position | Start |
|---|---|---|
| CORIUM INTERNATIONAL INC | Director/Board Member | - |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | 01/08/2017 |
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01/03/2020 |
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Director/Board Member | - |
Former positions of David S. Moore
| Companies | Position | End |
|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Chief Executive Officer | 01/03/2020 |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | President | 01/05/2019 |
| SIRONA BIOCHEM CORP. | Director/Board Member | 27/10/2017 |
| OCERA THERAPEUTICS INC | Corporate Officer/Principal | 01/07/2013 |
| Tranzyme Pharma, Inc. (Canada) | Corporate Officer/Principal | 01/06/2013 |
Training of David S. Moore
| Thomas Jefferson University | Undergraduate Degree |
| Lehigh University | Masters Business Admin |
| Towson University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SIRONA BIOCHEM CORP. | Health Technology |
| Private companies | 9 |
|---|---|
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| Tranzyme Pharma, Inc. (Canada) | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Tremeau Pharmaceuticals, Inc.
Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Health Technology |
Alladapt Immunotherapeutics, Inc.
 Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alladapt Immunotherapeutics, Inc. operates as a biopharmaceutical company developing prescription therapeutics targeting food allergy. The company was founded by Ashley Dombkowski and Kari Nadeau in 2018 and is headquartered in Menlo Park, CA. | Health Technology |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Stock Market
- Insiders
- David S. Moore
